Increased plasma DR‐70 (fibrinogen‐fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms

BACKGROUND: Tumor biomarkers have used widely in clinical oncology in human medicine. Only a few studies have evaluated the clinical utility of tumor biomarkers for veterinary medicine. A test for fibrinogen and fibrin degradation products (DR‐70) has been proposed as an ideal biomarker for tumors i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Chiao‐Hsu, Sio, Ka‐Mei, Wu, Chun‐Hung, Xia, Yuan‐Yuan, Lee, Jih‐Jong, Hu, Chin‐Hao, Liu, Cheng‐Chi, Lu, Chueh‐Ling, Cheng, Chiao‐Lei, Lin, Keng‐Hsuan, Tomiyasu, Hirotaka, Wang, Yu‐Shan, Lin, Chen‐Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658483/
https://www.ncbi.nlm.nih.gov/pubmed/37837297
http://dx.doi.org/10.1111/jvim.16898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658483/
https://www.ncbi.nlm.nih.gov/pubmed/37837297
http://dx.doi.org/10.1111/jvim.16898

Ejemplares similares